文献速递复苏、休克与脓毒症

院外心脏骤停患者骨内与静脉通路比较:一项回顾性队列研究

A comparison between intraosseous and intravenous access in patients with out-of-hospital cardiac arrest: A retrospective cohort study.
PubMed 文献 · Am J Emerg Med · 2024-04-09
一句话结论在EMT-P复苏的院外心脏骤停患者中,骨内通路与静脉通路患者结局相当,但女性和一般救护队复苏者静脉通路可能更有利。

这项回顾性队列研究纳入2019年1月1日至2022年12月31日台湾桃园市2003例成人非创伤性院外心脏骤停患者,比较骨内通路(401例)与静脉通路(1602例)对持续ROSC(≥2小时)和CPC 1-2的影响。骨内通路与静脉通路相比,持续ROSC的aOR为0.83(95%CI 0.61-1.11;p=0.20),CPC 1-2的aOR为0.96(95%CI 0.39-2.40;p=0.93),均无统计学显著差异。不同穿刺部位间结局无差异。在女性和一般救护队复苏亚组中,骨内通路持续ROSC的aOR分别为0.55(95%CI 0.33-0.92;p=0.02)和0.62(95%CI 0.41-0.94;p=0.02),静脉通路可能更有利。

要点

  • 在EMT-P复苏的成人非创伤性OHCA患者中,骨内通路与静脉通路的持续ROSC(≥2小时)无显著差异,aOR 0.83(95%CI 0.61-1.11;p=0.20)。
  • 骨内通路与静脉通路的CPC 1-2无显著差异,aOR 0.96(95%CI 0.39-2.40;p=0.93)。
  • 不同骨内穿刺部位之间患者结局无差异。
  • 女性患者中骨内通路持续ROSC的aOR为0.55(95%CI 0.33-0.92;p=0.02),静脉通路可能更有利。
  • 由一般救护队(EMT-P较少、骨内通路使用经验有限)复苏的患者中,骨内通路持续ROSC的aOR为0.62(95%CI 0.41-0.94;p=0.02),静脉通路可能更有利。

适用人群与场景

  • 纳入标准:年龄≥18岁、非创伤性院外心脏骤停、由急救技术员-护理人员(EMT-P)复苏、最终血管通路为静脉或骨内通路的患者。
  • 排除标准:来院途中发生心脏骤停者、冠状病毒大流行期间(2022年5月1日至2022年10月31日)复苏者。
  • 研究场景:台湾桃园市院前急救,研究时段为2019年1月1日至2022年12月31日。

研究设计与关键结果

  • 研究类型:回顾性队列研究;总样本量2003例,其中静脉通路1602例、骨内通路401例;患者中位年龄70岁,男性占66.6%。
  • 主要终点:持续ROSC(≥2小时),骨内通路 vs 静脉通路的aOR为0.83(95%CI 0.61-1.11;p=0.20),无统计学显著差异。
  • 次要终点:CPC 1-2,骨内通路 vs 静脉通路的aOR为0.96(95%CI 0.39-2.40;p=0.93),无统计学显著差异。
  • 不同骨内穿刺部位之间患者结局无差异。
  • 女性亚组:骨内通路 vs 静脉通路持续ROSC的aOR为0.55(95%CI 0.33-0.92;p=0.02)。
  • 一般救护队亚组:骨内通路 vs 静脉通路持续ROSC的aOR为0.62(95%CI 0.41-0.94;p=0.02)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于EMT-P复苏的成人非创伤性OHCA患者,骨内通路与静脉通路在患者结局上相当,但女性和由一般救护队复苏的患者中静脉通路可能更有利(作者认为)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: The optimal vascular access for patients with out-of-hospital cardiac arrest (OHCA) remains controversial. Increasing evidence supports intraosseous (IO) access due to faster medication administration and higher first-attempt success rates compared to intravenous (IV) access. However, the impact on patient outcomes has been inconclusive.

METHODS: This retrospective cohort study in Taoyuan City, Taiwan, from January 1, 2019, to December 31, 2022, included patients aged ≥18 years with non-traumatic OHCA resuscitated by emergency medical technician paramedics (EMT-Ps) with either IVs or IOs for final vascular access. The exclusion criteria were cardiac arrest en route to the hospital and resuscitation during the coronavirus pandemic (from May 1, 2022, to October 31, 2022). The primary and secondary outcomes were sustained ROSC (≥2 h) and cerebral performance category (CPC) 1-2, respectively. Univariate logistic regression was used to estimate the odds ratios (ORs) and 95% confidence intervals (CI) for the primary analysis. Multivariable logistic regression was employed, with variables selected based on a p-value of <0.05 in the univariate analysis. The survival benefits of different insertion sites and subgroups like general ambulance teams (with a composition that includes fewer EMT-Ps and limited experience in using IO access) were also analyzed.

RESULTS: A total of 2003 patients were enrolled; 1602 received IV access and 401 IO access. The median patient age was 70 years, and most were male (66.6%). Compared to patients receiving IV access, the adjusted odds ratios (aORs) for primary and secondary outcomes in patients with IOs were 0.83 (95% confidence interval [CI], 0.61-1.11; p = 0.20) and 0.96 (95% CI, 0.39-2.40; p = 0.93), respectively. Different insertion sites showed no outcome differences. In the subgroups of females and patients resuscitated by general ambulance teams, the aORs for sustained ROSC were 0.55 (95% CI, 0.33-0.92; p = 0.02) and 0.62 (95% CI, 0.41-0.94; p = 0.02), respectively.

CONCLUSIONS: For patients with OHCA resuscitated by EMT-Ps, IO access was comparable to IV access regarding patient outcomes. However, in females and patients resuscitated by general ambulance teams, IV access might be favorable.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Lee AF, Chang YH, Chien LT, et al. A comparison between intraosseous and intravenous access in patients with out-of-hospital cardiac arrest: A retrospective cohort study. Am J Emerg Med. 2024. PMID: 38608469. doi:10.1016/j.ajem.2024.04.009

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。